Efforts aimed at the discovery and development of small-molecule modulators of CFTR as therapeutic agents for CF have produced some promising results such as Kalydeco (ivacaftor, VX-770) and Orkambi (lumacaftor/ivacaftor). The gene discussed is CFTR; the disease is cystic fibrosis.